CEO Corner

31. How European Biopharmas Can Benefit From Establishing A U.S. Presence 8/2/2021

    The maturity and scale of the biotech industry in the U.S. can offer several competitive advantages, making expansion into the U.S. well worth considering for leaders of biopharma companies formed in other countries, such as across Europe.

32. Against All Odds: Advancing From R&D To Phase 3 7/1/2021

    There is nothing more rewarding than knowing that we can help save a life and give hope to patients and their friends and families. Because lives are at stake, there must be more regulations and processes to ensure safety and efficacy.

33. Capitalization, Coaching, And Clarity Are Keys To Success 7/1/2021

    Throughout my career, I have employed the following guiding principles to advance treatment options for patients: capitalization is king, hire the right people, and be decisive and humble.

34. From Academia to Industry – How Biopharma Entrepreneurship Became A Calling 6/1/2021

    While I knew that I wanted to dedicate my life to developing gene therapies to cure human diseases, I could not have predicted that I would leave academia to become an entrepreneur.

35. A Black CEO's Advice To The Next Generation 6/1/2021

    As one of the few African American CEOs in corporate America, I am in a unique position to share my experience with the next generation of leaders as we continue to face major challenges around inequity, intolerance, and community cohesion.

36. Coworking Lab Spaces Help Life Science Startups Succeed 5/3/2021

    While business incubators are not uncommon, facilities like these provide laboratory equipment and staff to manage safety, training, and other lab operations for entrepreneurs to reduce their initial investment expenses.

37. What I Learned As A Teacher That Made Me A Better Leader 4/1/2021

    Before I started my career in the pharmaceutical industry, I was a chemistry and biology teacher. While my days in the classroom now feel like a lifetime ago, a day rarely passes that I don't draw upon the range of skills I honed back then.

38. Never Let Success Go To Your Head — Or Failure Get To Your Heart 3/1/2021

    We all know most biotech ventures end in failure, but this does not make it any easier when you experience one, especially as a CEO.

39. How Small Patient Advocacy Groups Can Help Advance Drug Development 2/1/2021

    Working with large disease societies/organizations can streamline industry efforts to engage with specific patient groups, which can be especially beneficial when developing therapies in larger indications.

40. Bringing Global Business Perspectives To An Entrepreneurial Startup 2/1/2021

    Entrepreneurs and leaders who can create and implement the needed foundational cultural elements are the ones who find success.